| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/AJPGI.2001.280.5.G922 |
| P698 | PubMed publication ID | 11292601 |
| P2093 | author name string | A Allen | |
| L Holm | |||
| V Strugala | |||
| C Atuma | |||
| P433 | issue | 5 | |
| P304 | page(s) | G922-9 | |
| P577 | publication date | 2001-05-01 | |
| P1433 | published in | American Journal of Physiology - Gastrointestinal and Liver Physiology | Q15765756 |
| P1476 | title | The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo | |
| P478 | volume | 280 |
| Q47150486 | 3-Sulfogalactosyl-dependent adhesion of Escherichia coli HS multivalent adhesion molecule is attenuated by sulfatase activity |
| Q37448385 | A Mouse Intra-Intestinal Infusion Model and its Application to the Study of Nanoparticle Distribution. |
| Q64884142 | A Sensitive and Rapid Method to Determin the Adhesion Capacity of Probiotics and Pathogenic Microorganisms to Human Gastrointestinal Mucins. |
| Q57020925 | A Simple Gut Model for Studying the Interaction between and the Intestinal Commensal Microbiota in Cecal Mucus |
| Q57944630 | A Simple In Vitro Gut Model for Studying the Interaction between Escherichia coli and the Intestinal Commensal Microbiota in Cecal Mucus |
| Q41899045 | A combined small-angle X-ray and neutron scattering study of the structure of purified soluble gastrointestinal mucins. |
| Q90288067 | A fiber-deprived diet disturbs the fine-scale spatial architecture of the murine colon microbiome |
| Q44870856 | A microengineered collagen scaffold for generating a polarized crypt-villus architecture of human small intestinal epithelium |
| Q51538062 | A microfluidic in vitro system for the quantitative study of the stomach mucus barrier function |
| Q34815535 | A novel dispersin protein in enteroaggregative Escherichia coli |
| Q38343039 | A review of mixing and propulsion of chyme in the small intestine: fresh insights from new methods. |
| Q49884244 | A sticky end for gastrointestinal helminths; the role of the mucus barrier. |
| Q47899008 | A β-Glucan-Based Dietary Fiber Reduces Mast Cell-Induced Hyperpermeability in Ileum From Patients With Crohn's Disease and Control Subjects. |
| Q36115244 | Acid contact in the rodent pulmonary alveolus causes proinflammatory signaling by membrane pore formation |
| Q30824795 | Adhesion of the genome-sequenced Lactococcus lactis subsp. cremoris IBB477 strain is mediated by specific molecular determinants. |
| Q46963843 | Adhesion of vancomycin-resistant enterococcus to human intestinal mucus |
| Q95270406 | Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors |
| Q90446843 | Akkermansia muciniphila in the Human Gastrointestinal Tract: When, Where, and How? |
| Q38237646 | Alginate Particles as Platform for Drug Delivery by the Oral Route: State-of-the-Art |
| Q38625377 | An Immune Effector System in the Protochordate Gut Sheds Light on Fundamental Aspects of Vertebrate Immunity |
| Q33816839 | An ex vivo method for studying mucus formation, properties, and thickness in human colonic biopsies and mouse small and large intestinal explants. |
| Q30538893 | An exploration of the microrheological environment around the distal ileal villi and proximal colonic mucosa of the possum ( Trichosurus vulpecula ) |
| Q90580710 | Analysis of the colonic mucosa associated microbiota (MAM) using brushing samples during colonic endoscopic procedures |
| Q91106566 | Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability |
| Q34740052 | Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. |
| Q44447065 | Antibiotics conspicuously affect community profiles and richness, but not the density of bacterial cells associated with mucosa in the large and small intestines of mice |
| Q27321389 | Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model |
| Q30522343 | Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype. |
| Q42282143 | Bifidobacterium bifidum Extracellular Sialidase Enhances Adhesion to the Mucosal Surface and Supports Carbohydrate Assimilation |
| Q46376615 | Biological Aging and the Human Gut Microbiota |
| Q64949281 | Biopolymeric Mucin and Synthetic Polymer Analogs: Their Structure, Function and Role in Biomedical Applications. |
| Q28727713 | Breakdown of mucin as barrier to digestive enzymes in the ischemic rat small intestine |
| Q40071271 | Butyrate Supplementation at High Concentrations Alters Enteric Bacterial Communities and Reduces Intestinal Inflammation in Mice Infected with Citrobacter rodentium |
| Q54293626 | Capacity of the bovine intestinal mucus and its components to support growth of Escherichia coli O157:H7. |
| Q41813130 | Carbachol-induced colonic mucus formation requires transport via NKCC1, K⁺ channels and CFTR. |
| Q27678338 | Carbohydrate Recognition by an Architecturally Complex α-N-Acetylglucosaminidase from Clostridium perfringens |
| Q36312701 | Cell-specific effects of luminal acid, bicarbonate, cAMP, and carbachol on transporter trafficking in the intestine |
| Q64077456 | Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals |
| Q64929435 | Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems. |
| Q99710893 | Clinically adaptable polymer enables simultaneous spatial analysis of colonic tissues and biofilms |
| Q36605127 | Colonic MUC2 mucin regulates the expression and antimicrobial activity of β-defensin 2. |
| Q46031839 | Colonization, localization, and inflammation: the roles of H. pylori chemotaxis in vivo. |
| Q35694190 | Commensal and Pathogenic Escherichia coli Metabolism in the Gut. |
| Q35761363 | Comparative study of the intestinal mucus barrier in normal and inflamed colon. |
| Q50318826 | Comparison of different histological protocols for the preservation and quantification of the intestinal mucus layer in pigs |
| Q37938766 | Composition and functional role of the mucus layers in the intestine |
| Q37236336 | Coordination of Metabolism and Virulence Factors Expression of Extraintestinal Pathogenic Escherichia coli Purified from Blood Cultures of Patients with Sepsis |
| Q38200248 | Cryptosporidium infections: molecular advances |
| Q39259629 | Current state and challenges in developing oral vaccines |
| Q35605834 | Delivery of a mucin domain enriched in cysteine residues strengthens the intestinal mucous barrier |
| Q35009140 | Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays. |
| Q90831507 | Diet and the gut microbiome: from hype to hypothesis |
| Q42137911 | Dynamic molecular resolution imaging of preocular fluid impressions |
| Q37626305 | Early commitment and robust differentiation in colonic crypts |
| Q35893153 | Early detection of colonic dysplasia by magnetic resonance molecular imaging with a contrast agent raised against the colon cancer marker MUC5AC. |
| Q34665089 | Effect of antimicrobial growth promoter administration on the intestinal microbiota of beef cattle |
| Q64880477 | Effects of Different Diets on Microbiota in The Small Intestine Mucus and Weight Regulation in Rats. |
| Q43243335 | Endotoxin-induced changes in phospholipid dynamics of the stomach |
| Q38154804 | Engineering synthetic vaccines using cues from natural immunity |
| Q34695073 | Entamoeba histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective colonic mucus gel. |
| Q42515748 | Epithelial Barrier Regulation by Hypoxia-Inducible Factor. |
| Q37287149 | Escherichia coli O157:H7 Strain EDL933 Harbors Multiple Functional Prophage-Associated Genes Necessary for the Utilization of 5-N-Acetyl-9-O-Acetyl Neuraminic Acid as a Growth Substrate |
| Q86098274 | Essential role of the electroneutral Na+-HCO3- cotransporter NBCn1 in murine duodenal acid-base balance and colonic mucus layer build-up in vivo |
| Q91817427 | Establishing Boundaries: The Relationship That Exists between Intestinal Epithelial Cells and Gut-Dwelling Bacteria |
| Q37639440 | Eukaryotic protein glycosylation: a primer for histochemists and cell biologists |
| Q64055283 | Evaluating Shigella flexneri Pathogenesis in the Human Enteroid Model |
| Q37146161 | Evaluation of polyethylene oxide compacts as gastroretentive delivery systems |
| Q35916241 | Evidence for plasmid-mediated salt tolerance in the human gut microbiome and potential mechanisms. |
| Q60530559 | Evolutionary conservation of the antimicrobial function of mucus: a first defence against infection |
| Q38560347 | Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases |
| Q33701788 | Extracellular enolase of Candida albicans is involved in colonization of mammalian intestinal epithelium |
| Q33626756 | Factors that mediate colonization of the human stomach by Helicobacter pylori |
| Q27329920 | Food-associated stimuli enhance barrier properties of gastrointestinal mucus |
| Q34881370 | Galacto-oligosaccharides and Colorectal Cancer: Feeding our Intestinal Probiome |
| Q34838011 | Gastrointestinal cell lines form polarized epithelia with an adherent mucus layer when cultured in semi-wet interfaces with mechanical stimulation |
| Q85672918 | Gastroprotective bio-guiding study of fruits from Mimusops balata |
| Q46354358 | Glycosylation of human fetal mucins: a similar repertoire of O-glycans along the intestinal tract |
| Q92106368 | Gut Microbiome and Modulation of CNS Function |
| Q89805722 | Gut Microbiota, Antibiotic Therapy and Antimicrobial Resistance: A Narrative Review |
| Q34384235 | Helicobacter pylori: bacterial strategy for incipient stage and persistent colonization in human gastric niches |
| Q34467203 | Heterogeneity across the murine small and large intestine |
| Q33715804 | Homeostasis of the gut barrier and potential biomarkers |
| Q37787980 | Host‐bacteria interactions in the intestine: homeostasis to chronic inflammation |
| Q61248561 | Human intraepithelial lymphocytes |
| Q47874427 | Human microbiota, blood group antigens, and disease |
| Q91845019 | Immunity, microbiota and kidney disease |
| Q35596011 | Immunomodulatory mechanisms of lactobacilli |
| Q91235033 | Impact of bacteria motility in the encounter rates with bacteriophage in mucus |
| Q35825870 | Importance and regulation of the colonic mucus barrier in a mouse model of colitis |
| Q36127787 | Improved adhesive properties of recombinant bifidobacteria expressing the Bifidobacterium bifidum-specific lipoprotein BopA |
| Q99589896 | In Vitro Biopredictive Methods: A Workshop Summary Report |
| Q33901644 | In vivo analysis of mucosal lipids reveals histological disease activity in ulcerative colitis using endoscope-coupled Raman spectroscopy |
| Q42846896 | Inactivation of digestive proteases: another aspect of gut bacteria that should be taken into more consideration |
| Q90721023 | Inflammatory Bowel Disease: A Potential Result from the Collusion between Gut Microbiota and Mucosal Immune System |
| Q38843204 | Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets |
| Q38188656 | Inflammatory signals that regulate intestinal epithelial renewal, differentiation, migration and cell death: Implications for necrotizing enterocolitis |
| Q41479687 | Innate Immunity Modulation by the IL-33/ST2 System in Intestinal Mucosa |
| Q37800652 | Innate host barriers to viral trafficking and population diversity: lessons learned from poliovirus |
| Q92410522 | Intelligent magnetic manipulation for gastrointestinal ultrasound |
| Q39269431 | Interactions of Giardia sp. with the intestinal barrier: Epithelium, mucus, and microbiota |
| Q92702178 | Interleukin 1 is a key driver of inflammatory bowel disease-demonstration in a murine IL-1Ra knockout model |
| Q41677213 | Intestinal Host-Microbe Interactions under Physiological and Pathological Conditions |
| Q51168862 | Intestinal Muc2 mucin O-glycosylation is affected by microbiota and regulated by differential expression of glycosyltranferases. |
| Q38054086 | Intestinal antimicrobial peptides during homeostasis, infection, and disease |
| Q38009940 | Intestinal barrier function in health and gastrointestinal disease |
| Q34136264 | Intestinal epithelial cells in inflammatory bowel diseases |
| Q34102377 | Intestinal goblet cells and mucins in health and disease: recent insights and progress |
| Q24628739 | Intestinal microbiota in human health and disease: the impact of probiotics |
| Q90348786 | Intestinal mucus is capable of stabilizing supersaturation of poorly water-soluble drugs |
| Q34509140 | Intestinal mucus layer preservation in female rats attenuates gut injury after trauma-hemorrhagic shock |
| Q91638885 | Intrinsic Control of Surface Immune and Epithelial Homeostasis by Tissue-Resident Gut Stromal Cells |
| Q36544590 | Investigation of motility and biofilm formation by intestinal Campylobacter concisus strains. |
| Q36313802 | L-fucose stimulates utilization of D-ribose by Escherichia coli MG1655 DeltafucAO and E. coli Nissle 1917 DeltafucAO mutants in the mouse intestine and in M9 minimal medium |
| Q64062062 | Lactobacillus maintains healthy gut mucosa by producing L-Ornithine |
| Q34431205 | Lactobacillus reuteri maintains a functional mucosal barrier during DSS treatment despite mucus layer dysfunction. |
| Q33712829 | Laser capture microdissection and metagenomic analysis of intact mucosa-associated microbial communities of human colon |
| Q36294796 | Lawsonia intracellularis infection of intestinal crypt cells is associated with specific depletion of secreted MUC2 in goblet cells. |
| Q34071958 | Loss of the intestinal mucus layer in the normal rat causes gut injury but not toxic mesenteric lymph nor lung injury |
| Q39646395 | Lubiprostone Decreases Mouse Colonic Inner Mucus Layer Thickness and Alters Intestinal Microbiota |
| Q28087071 | Mammalian gastrointestinal tract parameters modulating the integrity, surface properties, and absorption of food-relevant nanomaterials |
| Q39268232 | Mathematical model of colitis-associated colon cancer |
| Q55311464 | Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Clostridium difficile Infections. |
| Q120829365 | Metabolic landscape of the male mouse gut identifies different niches determined by microbial activities |
| Q57193137 | Microbial interactions with the intestinal epithelium and beyond: Focusing on immune cell maturation and homeostasis |
| Q37961539 | Models for oral uptake of nanoparticles in consumer products |
| Q35187370 | Modified-chitosan/siRNA nanoparticles downregulate cellular CDX2 expression and cross the gastric mucus barrier |
| Q42624932 | Molecular aspects of mucoadhesive carrier development for drug delivery and improved absorption |
| Q42082396 | Morphological changes of cell proliferation and apoptosis in rat jejunal mucosa at different ages |
| Q33582232 | Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa |
| Q34313970 | Mucin Muc2 deficiency and weaning influences the expression of the innate defense genes Reg3β, Reg3γ and angiogenin-4. |
| Q37853367 | Mucin dynamics and enteric pathogens. |
| Q38411042 | Mucin glycan foraging in the human gut microbiome. |
| Q38705020 | Mucin-Microbiota Interaction During Postnatal Maturation of the Intestinal Ecosystem: Clinical Implications |
| Q34503629 | Mucin-bacterial interactions in the human oral cavity and digestive tract |
| Q37380400 | Mucin-type O-glycans and their roles in intestinal homeostasis |
| Q37349718 | Mucins in the mucosal barrier to infection. |
| Q64912446 | Mucus Architecture and Near-Surface Swimming Affect Distinct Salmonella Typhimurium Infection Patterns along the Murine Intestinal Tract. |
| Q46265634 | Mucus models to evaluate the diffusion of drugs and particles. |
| Q41447323 | Mucus organisation is shaped by colonic content; a new view. |
| Q35073162 | Mucus properties and goblet cell quantification in mouse, rat and human ileal Peyer's patches. |
| Q89135049 | Mucus-Pathogen Interactions in the Gastrointestinal Tract of Farmed Animals |
| Q91592802 | Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease |
| Q37153923 | Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues |
| Q89140629 | Mucus: An Underestimated Gut Target for Environmental Pollutants and Food Additives |
| Q34758294 | Neonatal Immune Adaptation of the Gut and Its Role during Infections |
| Q27021987 | Nitrate/Nitrite as Critical Mediators to Limit Oxidative Injury and Inflammation |
| Q40364679 | Nitrite in saliva increases gastric mucosal blood flow and mucus thickness. |
| Q37328491 | Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion |
| Q34098017 | Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptake |
| Q26738728 | Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues |
| Q33195001 | Oral and intestinal mucositis — causes and possible treatments |
| Q27023585 | Oral delivery of glucagon-like peptide-1 and analogs: alternatives for diabetes control? |
| Q38100911 | Oral delivery of proteins by biodegradable nanoparticles |
| Q35877982 | Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers |
| Q39433728 | Oxygen Metabolism and Innate Immune Responses in the Gut. |
| Q38921593 | Oxygen metabolism and barrier regulation in the intestinal mucosa |
| Q36392091 | Paneth cells and necrotizing enterocolitis |
| Q81803704 | Periodic fluid extrusion and models of digesta mixing in the intestine of a herbivore, the common brushtail possum (Trichosurus vulpecula) |
| Q91474296 | Permeability of the small intestinal mucus for physiologically relevant studies: Impact of mucus location and ex vivo treatment |
| Q36526607 | Perspectives on mucus properties and formation--lessons from the biochemical world |
| Q47791593 | Physicochemical properties of mucus and their impact on transmucosal drug delivery |
| Q36066325 | Physiologic hypoxia and oxygen homeostasis in the healthy intestine. A Review in the Theme: Cellular Responses to Hypoxia. |
| Q46398633 | Phytic acid increases mucin and endogenous amino acid losses from the gastrointestinal tract of chickens |
| Q38248999 | Planar bioadhesive microdevices: a new technology for oral drug delivery |
| Q38720389 | Plasticity of the brush border - the yin and yang of intestinal homeostasis |
| Q36808308 | Polymeric nanoparticle drug delivery technologies for oral delivery applications |
| Q34225096 | Polymeric nanoparticle technologies for oral drug delivery. |
| Q37065202 | Polymers in the gut compress the colonic mucus hydrogel. |
| Q35897397 | Postnatal Hematopoiesis and Gut Microbiota in NOD Mice Deviate from C57BL/6 Mice |
| Q33669559 | Postnatal development of the small intestinal mucosa drives age-dependent, regio-selective susceptibility to Escherichia coli K1 infection |
| Q38848225 | Potential role of probiotics in the management of gastric ulcer |
| Q37539275 | Preventive and therapeutic effects of nitrite supplementation in experimental inflammatory bowel disease. |
| Q40067237 | Probing the potential of mucus permeability to signify preterm birth risk |
| Q90320075 | Probiotics Ameliorate Colon Epithelial Injury Induced by Ambient Ultrafine Particles Exposure |
| Q55211531 | Prophylactic efficacy of orally administered Bacillus poly-γ-glutamic acid, a non-LPS TLR4 ligand, against norovirus infection in mice. |
| Q22306448 | Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself? |
| Q37172952 | Re-evaluation of the mechanisms of dietary fibre and implications for macronutrient bioaccessibility, digestion and postprandial metabolism |
| Q40689786 | Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane |
| Q35836653 | Regulation of virulence: the rise and fall of gastrointestinal pathogens. |
| Q33563572 | Relative bioavailability of chlorothiazide from mucoadhesive compacts in pigs |
| Q37851576 | Roadblocks in the gut: barriers to enteric infection |
| Q60908746 | Role of colonic microbiota in the pathogenesis of ulcerative colitis |
| Q27024137 | Role of commensal gut bacteria in inflammatory bowel diseases |
| Q37969288 | Role of mucus layers in gut infection and inflammation |
| Q114370871 | Rotavirus Interactions With Host Intestinal Epithelial Cells |
| Q37662549 | Sampling Strategies for Three-Dimensional Spatial Community Structures in IBD Microbiota Research |
| Q28817485 | Sex differences and effects of oestrogen in rat gastric mucosal defence |
| Q42555002 | Silane surface modification for improved bioadhesion of esophageal stents |
| Q34223385 | Small bowel review: Normal physiology, part 1. |
| Q51315856 | Small intestine mucosal adhesivity to in vivo capsule robot materials |
| Q35231320 | Spatial heterogeneity of gut microbiota reveals multiple bacterial communities with distinct characteristics |
| Q34760189 | Stimulation of Mucin, Mucus, and Viscosity during Lubiprostone in Patients with Chronic Constipation may Potentially Lead to Increase of Lubrication |
| Q92988278 | Strategies to promote abundance of Akkermansia muciniphila, an emerging probiotics in the gut, evidence from dietary intervention studies |
| Q30544011 | Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer's patches |
| Q37142603 | Studies of mucus in mouse stomach, small intestine, and colon. II. Gastrointestinal mucus proteome reveals Muc2 and Muc5ac accompanied by a set of core proteins |
| Q34801672 | Studies of mucus in mouse stomach, small intestine, and colon. III. Gastrointestinal Muc5ac and Muc2 mucin O-glycan patterns reveal a regiospecific distribution |
| Q27322154 | Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters |
| Q34033729 | Synthetic oral mucin mimic from polymer micelle networks |
| Q41442828 | Targeting Hypoxia to Augment Mucosal Barrier Function |
| Q90405711 | Targeting the gut barrier for the treatment of alcoholic liver disease |
| Q35232907 | Tea derived galloylated polyphenols cross-link purified gastrointestinal mucins |
| Q35326009 | Testing stem cell therapy in a rat model of inflammatory bowel disease: role of bone marrow stem cells and stem cell factor in mucosal regeneration |
| Q57120648 | The Brain-Gut-Microbiome Axis |
| Q36346259 | The Gut Microbiome: Connecting Spatial Organization to Function |
| Q30549931 | The Influence of Mucus Microstructure and Rheology in Helicobacter pylori Infection |
| Q41678805 | The Interaction of Large Bowel Microflora with the Colonic Mucus Barrier |
| Q58802621 | The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human |
| Q28478222 | The Rat IgGFcγBP and Muc2 C-Terminal Domains and TFF3 in Two Intestinal Mucus Layers Bind Together by Covalent Interaction |
| Q37034394 | The Reduction-insensitive Bonds of the MUC2 Mucin Are Isopeptide Bonds. |
| Q55011796 | The Role of Mucin in the Toxicological Impact of Polystyrene Nanoparticles. |
| Q33424509 | The Vibrio cholerae cytolysin promotes chloride secretion from intact human intestinal mucosa |
| Q33883184 | The distinct roles of anion transporters Slc26a3 (DRA) and Slc26a6 (PAT-1) in fluid and electrolyte absorption in the murine small intestine |
| Q34489494 | The evolution of mutualism in gut microbiota via host epithelial selection |
| Q28477738 | The extraordinarily complex but highly structured organization of intestinal mucus-gel unveiled in multicolor images |
| Q34332180 | The gastrointestinal mucus system in health and disease |
| Q62632794 | The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease |
| Q28594441 | The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria |
| Q42591549 | The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria |
| Q41508783 | The levels of Brachyspira hyodysenteriae binding to porcine colonic mucins differ between individuals, and binding is increased to mucins from infected pigs with de novo MUC5AC synthesis |
| Q34798439 | The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system |
| Q36505884 | The noncommensal bacterium Methylococcus capsulatus (Bath) ameliorates dextran sulfate (Sodium Salt)-Induced Ulcerative Colitis by influencing mechanisms essential for maintenance of the colonic barrier function |
| Q30667045 | The outer mucus layer hosts a distinct intestinal microbial niche. |
| Q41947622 | The role of Escherichia coli in inflammatory bowel disease |
| Q26851237 | The role of carbohydrates in infection strategies of enteric pathogens |
| Q33594436 | The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis |
| Q27301089 | The role of motility and chemotaxis in the bacterial colonization of protected surfaces |
| Q34959399 | The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis |
| Q34503613 | The role of the immune system in regulating the microbiota |
| Q33907419 | The sialate O-acetylesterase EstA from gut Bacteroidetes species enables sialidase-mediated cross-species foraging of 9-O-acetylated sialoglycans |
| Q26784036 | The stomach in health and disease |
| Q46166491 | The thickness of the intestinal mucous layer in the colon of rats fed various sources of non-digestible carbohydrates is positively correlated with the pool of SCFA but negatively correlated with the proportion of butyric acid in digesta |
| Q29617847 | The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions |
| Q27329973 | The uptake of soluble and particulate antigens by epithelial cells in the mouse small intestine |
| Q42320412 | The vermiform appendix and recurrent Clostridium difficile infection: a curious connection |
| Q26771122 | Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease |
| Q46301433 | Titanium Dioxide Nanoparticle Ingestion Alters Nutrient Absorption in an In Vitro Model of the Small Intestine. |
| Q24611219 | Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers |
| Q27336871 | Transport of particles in intestinal mucus under simulated infant and adult physiological conditions: impact of mucus structure and extracellular DNA |
| Q36765812 | Type 3 Muscarinic Receptors Contribute to Clearance of Citrobacter rodentium |
| Q92514325 | Using Microfluidics to Model Mucus |
| Q33775479 | Utility of in vivo transcription profiling for identifying Pseudomonas aeruginosa genes needed for gastrointestinal colonization and dissemination |
| Q26769025 | Vibrio cholerae Biofilms and Cholera Pathogenesis |
| Q42038460 | Virulent Shigella flexneri Affects Secretion, Expression, and Glycosylation of Gel-Forming Mucins in Mucus-Producing Cells |
| Q43124193 | Vulnerable sites and changes in mucin in the rat small intestine after non-steroidal anti-inflammatory drugs administration |
| Q94589381 | [The postbiotic HM0539 from Lactobacillus rhamnosus GG prevents intestinal infection by enterohemorrhagic E. coli O157: H7 in mice] |
| Q34972470 | iNOS-dependent increase in colonic mucus thickness in DSS-colitic rats |
| Q37655938 | γδ T-cell-deficient mice show alterations in mucin expression, glycosylation, and goblet cells but maintain an intact mucus layer |
Search more.